Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
67 Results for "
CST
" in MedChemExpress (MCE) Product Catalog:
Products (67)
67 Results for "CST" in MCE Product Catalog:
Cat. No.: HY-104035E
CAS No.: 63148-62-9
Synonyms: Poly(dimethylsiloxane) (PDMS), viscosity 100 CST (25 °C); Dimethylsilcone fluid, viscosity 100 CST (25 °C)
Cat. No.: HY-104035H
CAS No.: 63148-62-9
Synonyms: Poly(dimethylsiloxane) (PDMS), viscosity 10 CST (25 °C); Dimethylsilcone fluid, viscosity 10 CST (25 °C)
CST626 is a PROTAC degrader targeting IAP, with DC50 values of 0.7 nM, 2.4 nM and 6.2 nM against XIAP, cIAP1 and cIAP2, respectively. This compound recruits the VHL E3 ubiquitin ligase to form a heterotrimeric complex, thereby inducing ubiquitination and proteasomal degradation of the target proteins. CST626 also exhibits certain degrading activity against VHL30 and VHL19. CST626 inhibits the proliferation and induces apoptosis of various hematologic tumor cell lines, and its anti-tumor effect is further enhanced when used in combination with TNF-α. CST626 can be used in research related to multiple myeloma, acute myeloid leukemia and diffuse large B-cell lymphoma .
Cat. No.: HY-P1212
CAS No.: 193829-96-8
Synonyms: CST-14 (mouse, rat)
Target:
Research Areas:
Cat. No.: HY-78378
CAS No.: 470478-90-1
Target:
Research Areas:
4-(4-Boc-piperazinemethyl)phenylboronic acid pinacol ester is a PROTAC linker that can be used in the synthesis of CST905 (HY-175435) .
Cat. No.: HY-160502
CAS No.: 3093667-09-2
Target:
Research Areas:
CST967 (Compound 17) is a USP7 PROTAC degrader, and increasing the PROTAC concentration can enhance the degradation rate of USP7. CST967 can be used in cancer research .
Cat. No.: HY-P1139
CAS No.: 485803-62-1
Synonyms: PCFWKTCK
Target:
Research Areas:
Cat. No.: HY-150825
CAS No.: 847137-53-5
Target:
Research Areas:
CST530 is an inhibitor of apoptosis protein (IAP) antagonist. CST530 is an IAP-type Ligands for E3 Ligase. CST530 binds to the BIR3 domain of IAP and interferes with its function, thereby promoting the ubiquitination and degradation of cIAP1. CST530 can be used to prepare PROTACs .
Cat. No.: HY-134303
CAS No.: 2489241-16-7
Synonyms: PROTAC CDK4/6 degrader 34
CST651 (PROTAC CDK4/6 degrader 34) is a selective cyclin-dependent kinase CDK4/6 PROTAC degrader with DC50 values of 20 nM and 5.1 nM, respectively. CST651 recruits the VHL E3 ubiquitin ligase to mediate the ubiquitination and proteasomal degradation of CDK4/6. CST651 inhibits cancer cell proliferation and migration. CST651 can be used in research related to breast cancer, multiple myeloma, acute myeloid leukemia, and acute lymphoblastic leukemia .
Cat. No.: HY-W283166
CAS No.: 253678-67-0
Cat. No.: HY-175726
CAS No.: 3094183-96-4
Research Areas:
BRAF ligand-Linker Conjugate 1 is a target protein ligand-linker conjugate that can be used to synthesize PROTAC CST905(HY-175435) .
Cat. No.: HY-41747
CAS No.: 2413037-31-5
Research Areas:
BRAF ligand-1 is the ligand of BRAF. BRAF ligand-1 can be used to synthesize CST905 (HY-175435) .
Cat. No.: HY-RS03261
Target:
Research Areas:
CST1 Human Pre-designed siRNA Set A contains three designed siRNAs for CST1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS03262
Target:
Research Areas:
CST11 Human Pre-designed siRNA Set A contains three designed siRNAs for CST11 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS03263
Target:
Research Areas:
CST2 Human Pre-designed siRNA Set A contains three designed siRNAs for CST2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS03264
Target:
Research Areas:
CST3 Human Pre-designed siRNA Set A contains three designed siRNAs for CST3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS03265
Target:
Research Areas:
CST4 Human Pre-designed siRNA Set A contains three designed siRNAs for CST4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS03266
Target:
Research Areas:
CST5 Human Pre-designed siRNA Set A contains three designed siRNAs for CST5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS03267
Target:
Research Areas:
CST6 Human Pre-designed siRNA Set A contains three designed siRNAs for CST6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
